> Clinical Research Program
The Clinical Research Program (CRP) is located on
Ward 56 of Building 2 at Walter Reed Army Medical Center (WRAMC). Since
the opening of the renovated ward in July of 2000, CPDR has
increased staffing and the number and type of clinical trials in prostate
disease. The CRP at WRAMC offers military beneficiaries the opportunity
to participate in clinical trials for the prevention and treatment of
prostate disease.
Prostate Cancer is the most common non-skin cancer in America, affecting 1 in 6 men. A non-smoking man is more likely to develop prostate cancer than he is to develop colon, bladder, melanoma, lymphoma and kidney cancers combined. In fact, a man is 35% more likely to be diagnosed with prostate cancer than a woman is to be diagnosed with breast cancer.
In 2009, more than 186,000 men will be diagnosed with prostate cancer, and more than 28,000 men will die from the disease. One new case occurs every 2.5 minutes and a man dies from prostate cancer every 19 minutes.
It is estimated that there are more than 2 million American men currently living with prostate cancer.
The goal of CPDR's clinical research program is to combine prostate screening,
data collection, clinical diagnosis, education and counseling, and prostate
disease clinical trial research in an efficient, personal, patient oriented
center. This unique approach to the diagnosis and treatment of prostate
cancer and other prostate-related diseases has resulted in significant
clinical breakthroughs in these areas. In concert with the basic science
research program, the clinical research program's clinicians and researchers have achieved
a number of scientific discoveries through extensive patient observation
and data analysis.
In addition, the patient care
program is highly regarded among prostate cancer survivors, and CPDR
physicians are experts in the treatment of prostate cancer and other related diseases.
COL
David G. McLeod, 
